{
  "id": "resp_0db65c26b596eb3f00693c941e255c81939fa860aac1c7ff6c",
  "object": "response",
  "created_at": 1765577758,
  "status": "completed",
  "background": false,
  "billing": {
    "payer": "developer"
  },
  "error": null,
  "incomplete_details": null,
  "instructions": null,
  "max_output_tokens": null,
  "max_tool_calls": null,
  "model": "gpt-5.2-2025-12-11",
  "output": [
    {
      "id": "rs_0db65c26b596eb3f00693c941e6b748193b8b551fdee4b2f73",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0db65c26b596eb3f00693c94322b0081939d535afb001a14c3",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "\"PARP inhibitor\" drug code"
      }
    },
    {
      "id": "rs_0db65c26b596eb3f00693c9433db6481938d7f541ac45162b6",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0db65c26b596eb3f00693c9485bb248193823ba9fb7f6b7066",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "NCI drug dictionary olaparib small molecule inhibitor of poly(ADP-ribose) polymerase PARP1 PARP2"
      }
    },
    {
      "id": "rs_0db65c26b596eb3f00693c9488030c81939d4965fd0d2596b7",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0db65c26b596eb3f00693c9488f8c08193bf19466a844461ff",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "Definition of talazoparib NCI Drug Dictionary small molecule inhibitor PARP"
      }
    },
    {
      "id": "rs_0db65c26b596eb3f00693c948badfc8193ac263e5f294be56f",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0db65c26b596eb3f00693c948c65d081938a79b64ff75c6d56",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "Olaparib is a small-molecule drug NCI about-cancer treatment drugs olaparib"
      }
    },
    {
      "id": "rs_0db65c26b596eb3f00693c948edc848193a156b8d121f9d40b",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "ws_0db65c26b596eb3f00693c94948a508193829d53b2a3f4d623",
      "type": "web_search_call",
      "status": "completed",
      "action": {
        "type": "search",
        "query": "DailyMed TALZENNA talazoparib label Pfizer"
      }
    },
    {
      "id": "rs_0db65c26b596eb3f00693c9497f08c819399dbf54d2937af4a",
      "type": "reasoning",
      "summary": []
    },
    {
      "id": "msg_0db65c26b596eb3f00693c94c0ca4481939b38af2fb6dd6300",
      "type": "message",
      "status": "completed",
      "content": [
        {
          "type": "output_text",
          "annotations": [],
          "logprobs": [],
          "text": "{\n  \"validated\": false,\n  \"assets\": [],\n  \"rejected_reason\": \"Candidate identifier \\\"PARP inhibitor\\\" is a broad drug class (multiple distinct assets with different sponsors/indications/stages/geographies) rather than a single drug asset, and it does not match the requested CDK12/CDK12/13-targeted small molecule/PROTAC/glue degrader scope. Example PARP-inhibitor asset definition: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/olaparib\"\n}"
        }
      ],
      "role": "assistant"
    }
  ],
  "parallel_tool_calls": true,
  "previous_response_id": null,
  "prompt_cache_key": null,
  "prompt_cache_retention": null,
  "reasoning": {
    "effort": "xhigh",
    "summary": null
  },
  "safety_identifier": null,
  "service_tier": "default",
  "store": true,
  "temperature": 1.0,
  "text": {
    "format": {
      "type": "text"
    },
    "verbosity": "medium"
  },
  "tool_choice": "auto",
  "tools": [
    {
      "type": "web_search",
      "filters": null,
      "search_context_size": "medium",
      "user_location": {
        "type": "approximate",
        "city": null,
        "country": "US",
        "region": null,
        "timezone": null
      }
    }
  ],
  "top_logprobs": 0,
  "top_p": 0.98,
  "truncation": "disabled",
  "usage": {
    "input_tokens": 31147,
    "input_tokens_details": {
      "cached_tokens": 4736
    },
    "output_tokens": 10946,
    "output_tokens_details": {
      "reasoning_tokens": 10827
    },
    "total_tokens": 42093
  },
  "user": null,
  "metadata": {}
}